肿瘤学与功能结局支持对偶然发现的IDH突变胶质瘤进行早期切除
该研究回顾性分析了2011年6月至2022年4月在本中心手术切除的IDH突变弥漫性低级别胶质瘤(DLGG)患者,筛选出11例偶然发现者(iDLGG)。术后癫痫发作率为9.1%,45.4%患者出现肿瘤进展,平均进展时间42个月,3例(27.3%)出现轻度神经认知功能减退,其中1例(9.1%)妨碍重返工作。作者认为数据支持早期手术切除的安全性和有效性,但需更多研究。
要点
- 偶然发现的IDH突变DLGG术后癫痫发作率为9.1%。
- 45.4%患者出现肿瘤进展,平均进展时间42个月。
- 3例(27.3%)出现轻度神经认知减退,1例(9.1%)妨碍重返工作。
核心结论
- 尽管iDLGG的合适治疗方式仍存在争议,但本研究数据支持早期手术切除的安全性和有效性。
- 需要更多研究来牢固确立这种早期「预防性」手术方法。
研究设计与样本
- 回顾性连续系列研究,纳入2011年6月至2022年4月在本中心手术切除的成人DLGG患者,筛选出11例偶然发现者(iDLGG)。
- 通过液体衰减反转恢复磁共振成像的体积测量评估肿瘤体积、生长速率和切除程度(EOR)。
- 从患者数字档案中获取肿瘤学、功能性和癫痫相关结果数据。
主要发现
- 切除程度为超全切除、全切除和次全切除的比例分别为45.5%、26.4%和18.1%。
- 术后癫痫发作率为9.1%。
- 肿瘤进展比例为45.4%,总体平均肿瘤进展时间为42个月。
- 术后3例(27.3%)出现轻度神经认知功能减退,其中1例(9.1%)妨碍重返工作。
- 与既往系列相比,临床、影像学和分子特征无差异;功能性、手术、癫痫和肿瘤学结果也相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The main objective was to assess the neuropsychological, epileptical, and oncological outcomes in a series of patients operated on for a IDH-mutated diffuse low-grade glioma (DLGG) of incidental discovery (iDLGG). METHODS: We retrospectively reviewed a consecutive series of surgically treated adults with DLGG and selected cases incidentally discovered. Tumor volumes, growth rates, and extents of resection (EOR) were assessed by volumetric measures of fluid-attenuated inversion recovery magnetic resonance imaging. The data on oncological, functional, and epileptical results were retrieved from the patients' digital files. RESULTS: Among all patients with DLGG resected at our center between June 2011 and April 2022, we found eleven cases with an incidental discovery. Resection was supratotal, gross total, and subtotal in 45.5%, 26.4%, and 18.1% of cases, respectively. The rate of epileptic seizures after the surgery was 9.1%. There were 45.4% of patients that had tumor progressions and the overall mean time to tumor progression was 42 months. After the surgery, 3 (27.3%) patients had mild neurocognitive deteriorations, which impeded the return to work in one patient (9.1%). There were no differences with previous series regarding clinical, radiological, and molecular characteristics. Similar results were also found for functional, surgical, epileptical, and oncological outcomes. CONCLUSION: Although the right approach for iDLGG is still a matter of debate, our data support the safety and effectiveness of early surgical resection. More studies are needed to firmly ground this early "preventive" surgery approach.
引用
- Birladeanu A, Barberis M, Poisson I, et al. Oncological and functional outcomes support early resection of incidental IDH-mutated glioma. Acta Neurochir (Wien). 2023. PMID: 37672097. doi:10.1007/s00701-023-05788-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。